Clostridium Difficile Infection Treatment Market
Clostridium Difficile Infection Treatment Market : Table of Content
- Report code : PMRREP15775 |
- Industry : Life Sciences & Transformational Health |
- Published On : Nov-2019 |
- Pages : 160 Pages |
-
Format :
1. Executive Summary
1.1. Market Outlook
1.2. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market View Point
3.1. Macro-Economic Factors
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity Analysis
3.1.4. Trends
3.1.5. Forecast Factors
4. Global Clostridium difficile Infection Treatment Market (in Value or Size in US$ Mn) Analysis 2014-2018 and Forecast, 2019-2029
4.1. Historical Market Value (US$ Mn) Analysis, 2014-2018
4.2. Current and Future Market Value (US$ Mn) Projections, 2019-2029
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
4.2.3. Market Value Comparison
5. Global Clostridium difficile Infection Treatment Market Analysis 2014-2018 and Forecast 2019-2029, by Drug Type
5.1. Introduction / Key Findings
5.2. Historical Market Size (US$ Mn) Analysis By Drug Type, 2014-2018
5.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Drug Type, 2019 - 2029
5.3.1. Metronidazole
5.3.2. Vancomycin
5.3.3. Fidaxomicin
5.4. Market Attractiveness Analysis By Drug Type
6. Global Clostridium difficile Infection Treatment Market Analysis 2014-2018 and Forecast 2019-2029, by Route of Administration
6.1. Introduction / Key Findings
6.2. Historical Market Size (US$ Mn) Analysis By Route of Administration, 2014-2018
6.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Route of Administration, 2019 - 2029
6.3.1. Oral
6.3.2. Injectable
Market Attractiveness Analysis By Route of Administration
7. Global Clostridium difficile Infection Treatment Market Analysis 2014-2018 and Forecast 2019-2029, by Distribution Channel
7.1. Introduction / Key Findings
7.2. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2014-2018
7.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Distribution Channel, 2019 - 2029
7.3.1. Hospital Pharmacies
7.3.2. Retail Pharmacies
7.3.3. Mail Order Pharmacies
7.4. Market Attractiveness Analysis By Distribution Channel
8. Global Clostridium difficile Infection Treatment Market Analysis 2014-2018 and Forecast 2019-2029, by Region
8.1. Introduction
8.2. Historical Market Size (US$ Mn) Analysis By Region, 2014-2018
8.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2019 - 2029
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia
8.3.5. Middle East & Africa
8.4. Market Attractiveness Analysis By Region
9. North America Clostridium difficile Infection Treatment Market Analysis 2014-2018 and Forecast 2019-2029
9.1. Introduction
9.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2018
9.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019 - 2029
9.3.1. By Country
9.3.1.1. U.S.
9.3.1.2. Canada
9.3.2. By Drug Type
9.3.3. By Route of Administration
9.3.4. By Distribution Channel
9.4. Market Attractiveness Analysis
9.4.1. By Country
9.4.2. By Drug Type
9.4.3. By Route of Administration
9.4.4. By Distribution Channel
9.5. Drivers and Restraints: Impact Analysis
10. Latin America Clostridium difficile Infection Treatment Market Analysis 2014-2018 and Forecast 2019-2029
10.1. Introduction
10.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2018
10.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019 - 2029
10.3.1. By Country
10.3.1.1. Brazil
10.3.1.2. Mexico
10.3.1.3. Rest of Latin America
10.3.2. By Drug Type
10.3.3. By Route of Administration
10.3.4. By Distribution Channel
10.4. Market Attractiveness Analysis
10.4.1. By Country
10.4.2. By Drug Type
10.4.3. By Route of Administration
10.4.4. By Distribution Channel
10.5. Drivers and Restraints: Impact Analysis
11. Europe Clostridium difficile Infection Treatment Market Analysis 2014-2018 and Forecast 2019-2029
11.1. Introduction
11.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2018
11.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019 - 2029
11.3.1. By Country
11.3.1.1. Germany
11.3.1.2. Italy
11.3.1.3. France
11.3.1.4. U.K.
11.3.1.5. Spain
11.3.1.6. Russia
11.3.1.7. Rest of Europe
11.3.2. By Drug Type
11.3.3. By Route of Administration
11.3.4. By Distribution Channel
11.4. Market Attractiveness Analysis
11.4.1. By Country
11.4.2. By Drug Type
11.4.3. By Route of Administration
11.4.4. By Distribution Channel
11.5. Drivers and Restraints: Impact Analysis
12. Asia Clostridium difficile Infection Treatment Market Analysis 2014-2018 and Forecast 2019-2029
12.1. Introduction
12.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2018
12.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019 - 2029
12.3.1. By Country
12.3.1.1. Japan
12.3.1.2. China
12.3.1.3. India
12.3.1.4. ASEAN
12.3.1.5. Australia & New Zealand
12.3.1.6. Rest of Asia Pacific
12.3.2. By Drug Type
12.3.3. By Route of Administration
12.3.4. By Distribution Channel
12.4. Market Attractiveness Analysis
12.4.1. By Country
12.4.2. By Drug Type
12.4.3. By Route of Administration
12.4.4. By Distribution Channel
12.5. Drivers and Restraints: Impact Analysis
13. Middle East & Africa Clostridium difficile Infection Treatment Market Analysis 2014-2018 and Forecast 2019-2029
13.1. Introduction
13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2018
13.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019 - 2029
13.3.1. By Country
13.3.1.1. GCC Countries
13.3.1.2. South Africa
13.3.1.3. North Africa
13.3.1.4. Rest of MEA
13.3.2. By Drug Type
13.3.3. By Route of Administration
13.3.4. By Distribution Channel
13.4. Market Attractiveness Analysis
13.4.1. By Country
13.4.2. By Drug Type
13.4.3. By Route of Administration
13.4.4. By Distribution Channel
13.5. Drivers and Restraints: Impact Analysis
14. Competition Analysis
14.1. Competition Dashboard
14.2. Competition Deep Dive
14.2.1. Merck & Co., Inc
14.2.1.1. Overview
14.2.1.2. Drug Portfolio
14.2.1.3. Profitability by Market Segments (Drug/Channel/Region)
14.2.1.4. Sales Footprint
14.2.1.5. Strategy Overview
14.2.1.5.1. Marketing Strategy
14.2.1.5.2. Drug Strategy
14.2.1.5.3. Channel Strategy
14.2.2. Baxter International Inc.
14.2.2.1. Overview
14.2.2.2. Drug Portfolio
14.2.2.3. Profitability by Market Segments (Drug/Channel/Region)
14.2.2.4. Sales Footprint
14.2.2.5. Strategy Overview
14.2.2.5.1. Marketing Strategy
14.2.2.5.2. Drug Strategy
14.2.2.5.3. Channel Strategy
14.2.3. Sanofi S.A.
14.2.3.1. Overview
14.2.3.2. Drug Portfolio
14.2.3.3. Profitability by Market Segments (Drug/Channel/Region)
14.2.3.4. Sales Footprint
14.2.3.5. Strategy Overview
14.2.3.5.1. Marketing Strategy
14.2.3.5.2. Drug Strategy
14.2.3.5.3. Channel Strategy
14.2.4. Pfizer Inc.
14.2.4.1. Overview
14.2.4.2. Drug Portfolio
14.2.4.3. Profitability by Market Segments (Drug/Channel/Region)
14.2.4.4. Sales Footprint
14.2.4.5. Strategy Overview
14.2.4.5.1. Marketing Strategy
14.2.4.5.2. Drug Strategy
14.2.4.5.3. Channel Strategy
14.2.5. Novartis AG
14.2.5.1. Overview
14.2.5.2. Drug Portfolio
14.2.5.3. Profitability by Market Segments (Drug/Channel/Region)
14.2.5.4. Sales Footprint
14.2.5.5. Strategy Overview
14.2.5.5.1. Marketing Strategy
14.2.5.5.2. Drug Strategy
14.2.5.5.3. Channel Strategy
14.2.6. Astellas Pharma
14.2.6.1. Overview
14.2.6.2. Drug Portfolio
14.2.6.3. Profitability by Market Segments (Drug/Channel/Region)
14.2.6.4. Sales Footprint
14.2.6.5. Strategy Overview
14.2.6.5.1. Marketing Strategy
14.2.6.5.2. Drug Strategy
14.2.6.5.3. Channel Strategy
14.2.7. Eli LilIy & Company
14.2.7.1. Overview
14.2.7.2. Drug Portfolio
14.2.7.3. Profitability by Market Segments (Drug/Channel/Region)
14.2.7.4. Sales Footprint
14.2.7.5. Strategy Overview
14.2.7.5.1. Marketing Strategy
14.2.7.5.2. Drug Strategy
14.2.7.5.3. Channel Strategy
14.2.8. AstraZeneca
14.2.8.1. Overview
14.2.8.2. Drug Portfolio
14.2.8.3. Profitability by Market Segments (Drug/Channel/Region)
14.2.8.4. Sales Footprint
14.2.8.5. Strategy Overview
14.2.8.5.1. Marketing Strategy
14.2.8.5.2. Drug Strategy
14.2.8.5.3. Channel Strategy
14.2.9. Actelion Pharmaceuticals Ltd (Sub. of Johnson & Johnson Services, Inc.)
14.2.9.1. Overview
14.2.9.2. Drug Portfolio
14.2.9.3. Profitability by Market Segments (Drug/Channel/Region)
14.2.9.4. Sales Footprint
14.2.9.5. Strategy Overview
14.2.9.5.1. Marketing Strategy
14.2.9.5.2. Drug Strategy
14.2.9.5.3. Channel Strategy
14.2.10. Mylan N.V.
14.2.10.1. Overview
14.2.10.2. Drug Portfolio
14.2.10.3. Profitability by Market Segments (Drug/Channel/Region)
14.2.10.4. Sales Footprint
14.2.10.5. Strategy Overview
14.2.10.5.1. Marketing Strategy
14.2.10.5.2. Drug Strategy
14.2.10.5.3. Channel Strategy
15. Assumptions and Acronyms Used
16. Research Methodology
List of Table
Table 01: Clostridium difficile Infection Treatment Market Value (US$ Mn) Growth Comparison
Table 02: Global Clostridium difficile Infection Treatment Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Drug Type
Table 03: Global Clostridium difficile Infection Treatment Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Route of Administration
Table 04: Global Clostridium difficile Infection Treatment Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Distribution Channel
Table 05: Global Clostridium difficile Infection Treatment Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Region
Table 06: North America Clostridium difficile Infection Treatment Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Country
Table 07: North America Clostridium difficile Infection Treatment Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Drug Type
Table 08: North America Clostridium difficile Infection Treatment Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Route of Administration
Table 09: North America Clostridium difficile Infection Treatment Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Distribution Channel
Table 10: Latin America Clostridium difficile Infection Treatment Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Country
Table 11: Latin America Clostridium difficile Infection Treatment Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Drug Type
Table 12: Latin America Clostridium difficile Infection Treatment Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Route of Administration
Table 13: Latin America Clostridium difficile Infection Treatment Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Distribution Channel
Table 14: Europe Clostridium difficile Infection Treatment Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Country
Table 15: Europe Clostridium difficile Infection Treatment Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Drug Type
Table 16: Europe Clostridium difficile Infection Treatment Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Route of Administration
Table 17: Europe Clostridium difficile Infection Treatment Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Distribution Channel
Table 18: Asia Pacific Clostridium difficile Infection Treatment Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Country
Table 19: Asia Pacific Clostridium difficile Infection Treatment Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Drug Type
Table 20: Asia Pacific Clostridium difficile Infection Treatment Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Route of Administration
Table 21: Asia Pacific Clostridium difficile Infection Treatment Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Distribution Channel
Table 22: MEA Clostridium difficile Infection Treatment Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Country
Table 23: MEA Clostridium difficile Infection Treatment Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Drug Type
Table 24: MEA Clostridium difficile Infection Treatment Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Route of Administration
Table 25: MEA Clostridium difficile Infection Treatment Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Distribution Channel
List of Figure
Figure 01: Global Clostridium difficile Infection Treatment Market Value Share, By Drug Type (2019E)
Figure 02: Global Clostridium difficile Infection Treatment Market Value Share, By Route of Administration (2019E)
Figure 03: Global Clostridium difficile Infection Treatment Market Value Share, By Distribution Channel (2019E)
Figure 04: Antimicrobial Drugs (AD) Use in Acute Care Hospitals in the U.S
Figure 05: Trends in Origin of C. difficile Infection in Europe (2017)
Figure 06: Antimicrobial Drugs (AD) Use in Acute Care Hospitals in the U.S
Figure 07: Global Clostridium difficile Infection Treatment Market Value Analysis (US$ Mn), 2014–2018
Figure 08: Incidence of C. difficile Infection Across Major Countries as Percentage of Total Hospital Admissions (2016)
Figure 08: Global Clostridium difficile Infection Treatment Market Value Forecast (US$ Mn), 2019–2029
Figure 09: Global Clostridium difficile Infection Treatment Market Absolute $ Opportunity, 2019–2029
Figure 10: Comparison January 2018 and November 2019, Y-o-Y Forecast
Figure 11: Global Clostridium difficile Infection Treatment Market Share Analysis (%), By Drug Type, 2019 & 2029
Figure 12: Global Clostridium difficile Infection Treatment Market Y-o-Y Analysis (%), By Drug Type, 2019–2029
Figure 13: Global Clostridium difficile Infection Treatment Market Attractiveness Analysis By Drug Type, 2019–2029
Figure 14: Global Clostridium difficile Infection Treatment Market Share Analysis (%), By Route of Administration, 2019 & 2029
Figure 15: Global Clostridium difficile Infection Treatment Market Y-o-Y Analysis (%), By Route of Administration, 2019–2029
Figure 16: Global Clostridium difficile Infection Treatment Market Attractiveness Analysis By Route of Administration, 2019–2029
Figure 17: Global Clostridium difficile Infection Treatment Market Share Analysis (%), By Distribution Channel, 2019 & 2029
Figure 18: Global Clostridium difficile Infection Treatment Market Y-o-Y Analysis (%), By Distribution Channel, 2019–2029
Figure 19: Global Clostridium difficile Infection Treatment Market Attractiveness Analysis Distribution Channel, 2019–2029
Figure 20: Global Clostridium difficile Infection Treatment Market Share Analysis (%), By Region, 2019 & 2029
Figure 21: Global Clostridium difficile Infection Treatment Market Y-o-Y Analysis (%), By Region, 2019–2029
Figure 22: Global Clostridium difficile Infection Treatment Market Attractiveness Analysis, By Region, 2019–2029
Figure 23: North America Clostridium difficile Infection Treatment Market Value Share, By Drug Type, 2019 (E)
Figure 24: North America Clostridium difficile Infection Treatment Market Value Share, By Route of Administration, 2019 (E)
Figure 25: North America Clostridium difficile Infection Treatment Market Value Share, By Distribution Channel, 2019 (E)
Figure 26: North America Clostridium difficile Infection Treatment Market Value Share, By Country, 2019 (E)
Figure 27: North America Clostridium difficile Infection Treatment Market Forecast 2019 and 2029
Figure 28: North America Clostridium difficile Infection Treatment Market Value Analysis (US$ Mn), 2014–2018
Figure 29: North America Clostridium difficile Infection Treatment Market Value Forecast (US$ Mn), 2019–2029
Figure 30: North America Clostridium difficile Infection Treatment Market Attractiveness Analysis By Drug Type, 2019–2029
Figure 31: North America Clostridium difficile Infection Treatment Market Attractiveness Analysis By Route of Administration, 2019–2029
Figure 31: North America Clostridium difficile Infection Treatment Market Attractiveness Analysis By Distribution Channel, 2019–2029
Figure 33: North America Clostridium difficile Infection Treatment Market Attractiveness Analysis By Country, 2019–2029
Figure 34: Latin America Clostridium difficile Infection Treatment Market Value Share, By Drug Type, 2019 (E)
Figure 35: Latin America Clostridium difficile Infection Treatment Market Value Share, By Route of Administration, 2019 (E)
Figure 36: Latin America Clostridium difficile Infection Treatment Market Value Share, By Distribution Channel, 2019 (E)
Figure 37: Latin America Clostridium difficile Infection Treatment Market Value Share, By Country, 2019 (E)
Figure 38: Latin America Clostridium difficile Infection Treatment Market Forecast 2019 and 2029
Figure 40: Latin America Clostridium difficile Infection Treatment Market Value Forecast (US$ Mn), 2019–2029
Figure 41: Latin America Clostridium difficile Infection Treatment Market Attractiveness Analysis By Drug Type, 2019–2029
Figure 42: Latin America Clostridium difficile Infection Treatment Market Attractiveness Analysis By Route of Administration, 2019–2029
Figure 43: Latin America Clostridium difficile Infection Treatment Market Attractiveness Analysis By Distribution Channel, 2019–2029
Figure 44: Latin America Clostridium difficile Infection Treatment Market Attractiveness Analysis By Country, 2019–2029
Figure 45: Europe Clostridium difficile Infection Treatment Market Value Share, By Drug Type, 2019 (E)
Figure 46: Europe Clostridium difficile Infection Treatment Market Value Share, By Route of Administration, 2019 (E)
Figure 47: Europe Clostridium difficile Infection Treatment Market Value Share, By Distribution Channel, 2019 (E)
Figure 48: Europe Clostridium difficile Infection Treatment Market Value Share, By Country, 2019 (E)
Figure 49: Europe Clostridium difficile Infection Treatment Market Forecast 2019 and 2029
Figure 50: Europe Clostridium difficile Infection Treatment Market Value Analysis (US$ Mn), 2014–2018
Figure 51: Europe Clostridium difficile Infection Treatment Market Value Forecast (US$ Mn), 2019–2029
Figure 52: Europe Clostridium difficile Infection Treatment Market Attractiveness Analysis By Drug Type, 2019–2029
Figure 53: Europe Clostridium difficile Infection Treatment Market Attractiveness Analysis By Route of Administration, 2019–2029
Figure 54: Europe Clostridium difficile Infection Treatment Market Attractiveness Analysis By Distribution Channel, 2019–2029
Figure 55: Europe Clostridium difficile Infection Treatment Market Attractiveness Analysis By Country, 2019–2029
Figure 56: Asia Pacific Clostridium difficile Infection Treatment Market Value Share, By Drug Type, 2019 (E)
Figure 57: Asia Pacific Clostridium difficile Infection Treatment Market Value Share, By Route of Administration, 2019 (E)
Figure 58: Asia Pacific Clostridium difficile Infection Treatment Market Value Share, By Distribution Channel, 2019 (E)
Figure 59: Asia Pacific Clostridium difficile Infection Treatment Market Value Share, By Country, 2019 (E)
Figure 60: Asia Pacific Clostridium difficile Infection Treatment Market Forecast 2019 and 2029
Figure 61: Asia Pacific Clostridium difficile Infection Treatment Market Value Analysis (US$ Mn), 2014–2018
Figure 62: Asia Pacific Clostridium difficile Infection Treatment Market Value Forecast (US$ Mn), 2019–2029
Figure 63: Asia Pacific Clostridium difficile Infection Treatment Market Attractiveness Analysis By Drug Type, 2019–2029
Figure 64: Asia Pacific Clostridium difficile Infection Treatment Market Attractiveness Analysis By Route of Administration, 2019–2029
Figure 65: Asia Pacific Clostridium difficile Infection Treatment Market Attractiveness Analysis By Distribution Channel, 2019–2029
Figure 66: Asia Pacific Clostridium difficile Infection Treatment Market Attractiveness Analysis By Country, 2019–2029
Figure 67: MEA Clostridium difficile Infection Treatment Market Value Share, By Drug Type, 2019 (E)
Figure 68: MEA Clostridium difficile Infection Treatment Market Value Share, By Route of Administration, 2019 (E)
Figure 69: MEA Clostridium difficile Infection Treatment Market Value Share, By Distribution Channel, 2019 (E)
Figure 70: MEA Clostridium difficile Infection Treatment Market Value Share, By Country, 2019 (E)
Figure 71: MEA Clostridium difficile Infection Treatment Market Forecast 2019 and 2029
Figure 72: MEA Clostridium difficile Infection Treatment Market Value Analysis (US$ Mn), 2014–2018
Figure 73: MEA Clostridium difficile Infection Treatment Market Value Forecast (US$ Mn), 2019–2029
Figure 74: MEA Clostridium difficile Infection Treatment Market Attractiveness Analysis By Drug Type, 2019–2029
Figure 75: MEA Clostridium difficile Infection Treatment Market Attractiveness Analysis By Route of Administration, 2019–2029
Figure 76: MEA Clostridium difficile Infection Treatment Market Attractiveness Analysis By Distribution Channel, 2019–2029
Figure 77: MEA Clostridium difficile Infection Treatment Market Attractiveness Analysis By Country, 2019–2029
Clostridium Difficile Infection Treatment Market - Table of Content
